Iyw

idarubicin, 42-43, 54, 64, 491-492 imatinib, 491

imatinib mesylate, 490, 497 immunoglobulin gene IgH, 107 immunohistochemistry, 33 immunophenotyping, 33 indolent lymphoproliferative disorders, 489 induction chemotherapy, 42-43 induction therapy, 65-66 infliximab, 441

interferon, 291-292, 295-297, 1107-1108

interferon a, 470-471, 497

intermediate chromosomal abnormalities, 45

internal tandem duplication (ITD), 46, 63

International Agency for Research on Cancer (IARC), 3

International Prognostic Index (IPI), 506, 743-744

International Prognostic Scoring System, 490

International Workshop on Chronic Lymphocytic Leukemia

(IWCLL), 237 inv(16)(p13q22)/ t(16;16)(p13;q22), 10-11 irinotecan hydrochloride (CPT-11), 664

0 0

Post a comment